메뉴 건너뛰기




Volumn 368, Issue 19, 2013, Pages 1800-1808

N-3 fatty acids in patients with multiple cardiovascular risk factors

(1,000)  Roncaglioni, M C d   Tombesi, M d   Avanzini, F d   Barlera, S d   Caimi, V d   Longoni, P d   Marzona, I d   Milani, V d   Silletta, M G d   Tognoni, G d   Marchioli, R d   Nicolis, E B d   Casola, C d   Massa, E d   Marrocco, W d   Micalella, M d   Franzosi, M G d   Geraci, E d   Giansiracusa, N d   Rocchetti, L d   more..

d NONE

Author keywords

[No Author keywords available]

Indexed keywords

OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO;

EID: 84877624255     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1205409     Document Type: Article
Times cited : (470)

References (13)
  • 1
    • 79959484739 scopus 로고    scopus 로고
    • n-3 Fatty acids in cardiovascular disease
    • De Caterina R. n-3 Fatty acids in cardiovascular disease. N Engl J Med 2011; 364:2439-50.
    • (2011) N Engl J Med , vol.364 , pp. 2439-2450
    • De Caterina, R.1
  • 2
    • 0345109256 scopus 로고    scopus 로고
    • Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
    • Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico [Errata, Lancet 2001;357:642, 2007;369:106.]
    • Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55. [Errata, Lancet 2001;357:642, 2007;369:106.]
    • (1999) Lancet , vol.354 , pp. 447-455
  • 3
    • 53049110571 scopus 로고    scopus 로고
    • Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial
    • GISSI-HF Investigators
    • GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1223-30.
    • (2008) Lancet , vol.372 , pp. 1223-1230
  • 4
    • 0035852471 scopus 로고    scopus 로고
    • Low dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
    • Collaborative Group of the Primary Prevention Project
    • Collaborative Group of the Primary Prevention Project. Low dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001;357:89-95.
    • (2001) Lancet , vol.357 , pp. 89-95
  • 5
    • 16544394556 scopus 로고    scopus 로고
    • How general practitioners perceive and grade the cardiovascular risk of their patients
    • Roncaglioni MC, Avanzini F, Roccatagliata D, et al. How general practitioners perceive and grade the cardiovascular risk of their patients. Eur J Cardiovasc Prev Rehabil 2004;11:233-8.
    • (2004) Eur J Cardiovasc Prev Rehabil , vol.11 , pp. 233-238
    • Roncaglioni, M.C.1    Avanzini, F.2    Roccatagliata, D.3
  • 6
    • 33846919426 scopus 로고    scopus 로고
    • Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level
    • Roccatagliata D, Avanzini F, Monesi L, at al. Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level. Vasc Health Risk Manag 2006;2:507-14.
    • (2006) Vasc Health Risk Manag , vol.2 , pp. 507-514
    • Roccatagliata, D.1    Avanzini, F.2    Monesi, L.3
  • 7
    • 26244455950 scopus 로고    scopus 로고
    • Appropriate use of antiplatelets: Is prescription in daily practice influenced by the global cardiovascular risk?
    • Monesi L, Avanzini F, Barlera S, et al. Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk? Eur J Clin Pharmacol 2005;61:595-601.
    • (2005) Eur J Clin Pharmacol , vol.61 , pp. 595-601
    • Monesi, L.1    Avanzini, F.2    Barlera, S.3
  • 8
    • 77955148343 scopus 로고    scopus 로고
    • Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: Rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomized trial in general practice
    • Rischio and Prevenzione Investigators
    • Rischio and Prevenzione Investigators. Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomized trial in general practice. Trials 2010;11:68.
    • (2010) Trials , vol.11 , pp. 68
  • 9
    • 0023148189 scopus 로고
    • Feasibility of a large prospective study in general practice: An Italian experience
    • Avanzini F, Alli C, Bettelli G, et al. Feasibility of a large prospective study in general practice: an Italian experience. BMJ 1987;294:157-60.
    • (1987) BMJ , vol.294 , pp. 157-160
    • Avanzini, F.1    Alli, C.2    Bettelli, G.3
  • 11
    • 33947583493 scopus 로고    scopus 로고
    • Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis
    • Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-8.
    • (2007) Lancet , vol.369 , pp. 1090-1098
    • Yokoyama, M.1    Origasa, H.2    Matsuzaki, M.3
  • 12
    • 84864219466 scopus 로고    scopus 로고
    • n-3 Fatty acids and cardiovascular outcomes in patients with dysglycemia
    • The ORIGIN Trial Investigators
    • The ORIGIN Trial Investigators. n-3 Fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012;367:309-18.
    • (2012) N Engl J Med , vol.367 , pp. 309-318
  • 13
    • 0037161373 scopus 로고    scopus 로고
    • Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione
    • Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897-903.
    • (2002) Circulation , vol.105 , pp. 1897-1903
    • Marchioli, R.1    Barzi, F.2    Bomba, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.